promethazine hydrochloride 1.25 MG/ML Oral Solution

What the CMS Formulary Data Shows for promethazine hydrochloride 1.25 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, promethazine hydrochloride 1.25 MG/ML Oral Solution (RxNorm concept RXCUI 992432, generic name promethazine hydrochloride) appears on 220 distinct formulary files spanning 3,677 Medicare Part D plan offerings - 72.6% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.4.

Real-world access to promethazine hydrochloride 1.25 MG/ML Oral Solution depends on utilization management as much as tier placement: 56.8% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 523,738 Part D beneficiaries filled promethazine hydrochloride 1.25 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $16,549,733 and an average per-beneficiary annual cost of $31.60. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry promethazine hydrochloride 1.25 MG/ML Oral Solution today.